BMPR2 and systemic sclerosis: Defective BMPRII signalling may contribute to disease pathogenesis by the reported enhanced expression and availability of the cytokines endotheline-1(ET-1) and transforming growth factor beta (TGF-β), both of which are implicated in disease pathogenesis and are unregulated in SSc and PAH.